Shahnjayla K. Connors
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shahnjayla K. Connors has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Ganna Chornokur
Department of Cancer Epidemiology , Division of Population Sciences, H. Lee Moffitt Cancer Center and Research Institute , Tampa , Florida , USA
1 shared publicationNagi B. Kumar
Department of Cancer Epidemiology , Division of Population Sciences, H. Lee Moffitt Cancer Center and Research Institute , Tampa , Florida , USA
1 shared publication
Latest Publications
- 1 January 2012
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 64 (1) , 4-22
New Insights Into the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate Cancer
Prostate cancer is the most commonly diagnosed cancer and second most common cause of cancer deaths in American men. Its long latency, slow progression, and high incidence rate make prostate cancer ideal for targeted chemopreventative therapies. Therefore, chemoprevention studies and clinical trials are essential for reducing the burden of prostate cancer on society. Epidemiological studies suggest that tea consumption has protective effects against a variety of human cancers, including that of the prostate. Laboratory and clinical studies have demonstrated that green tea components, specifically the green tea catechin (GTC) epigallocatechin gallate, can induce apoptosis, suppress progression, and inhibit invasion and metastasis of prostate cancer. Multiple mechanisms are involved in the chemoprevention of prostate cancer with GTCs; understanding and refining models of fundamental molecular pathways by which GTCs modulate prostate carcinogenesis is essential to apply the utilization of green tea for the chemoprevention of prostate cancer in clinical settings. The objective of this article is to review and summarize the most current literature focusing on the major mechanisms of GTC chemopreventative action on prostate cancer from laboratory, in vitro, and in vivo studies, and clinical chemoprevention trials.
- 1 January 2012
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 64 (1) , 4-22
New Insights Into the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate Cancer
Prostate cancer is the most commonly diagnosed cancer and second most common cause of cancer deaths in American men. Its long latency, slow progression, and high incidence rate make prostate cancer ideal for targeted chemopreventative therapies. Therefore, chemoprevention studies and clinical trials are essential for reducing the burden of prostate cancer on society. Epidemiological studies suggest that tea consumption has protective effects against a variety of human cancers, including that of the prostate. Laboratory and clinical studies have demonstrated that green tea components, specifically the green tea catechin (GTC) epigallocatechin gallate, can induce apoptosis, suppress progression, and inhibit invasion and metastasis of prostate cancer. Multiple mechanisms are involved in the chemoprevention of prostate cancer with GTCs; understanding and refining models of fundamental molecular pathways by which GTCs modulate prostate carcinogenesis is essential to apply the utilization of green tea for the chemoprevention of prostate cancer in clinical settings. The objective of this article is to review and summarize the most current literature focusing on the major mechanisms of GTC chemopreventative action on prostate cancer from laboratory, in vitro, and in vivo studies, and clinical chemoprevention trials.